Open original FDA record ↗Recall record
- FDA identifier
- Z-2694-2017
- Company in FDA record
- St. Jude Medical, Inc.
- FDA record creation date
- Jul 7, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The firm discovered a risk of loss of Neuromodulation therapy due to exposure of the IPG to monopolar electrosurgical devices (ESU) during medical procedures.
Source facts
- Action
- The notification material is in the form of a Physician Letter and Patient letter which will be delivered to physicians and patients in the US. The physician mailing will be initiated June 2, 2017 for delivery on June 7-9, 2017. The physicians were provided with patient management recommendations, Step for the patient controller updates, and Clinician's Manual Revised Warning. The Patient mailings will begin the week of June 12, 2017 to allow for clinician notification and are expected to be delivered within 3-5 business days. The patient letter informs of them of the potential for the loss of therapy and the steps to receive the software upgrade.
- Initiated
- 2017-06-02
- Root cause
- Device Design
- Terminated
- 2022-08-24
- Distribution
- US Nationwide Distribution
- Recall number
- Z-2694-2017
- Recall status
- Terminated
- CDRH record ID
- 156180
- FDA record created
- 2017-07-07
- Recall event number
- 77509